ISSN:

Journal Home

Alzheimer's Research and Therapy Q1 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Alzheimer's Research and Therapy is a journal indexed in SJR in Neurology (clinical) and Cognitive Neuroscience with an H index of 97. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1529 €. The scope of the journal is focused on Alzheimer's disease, dementia, neurodegenerative diseases. It has an SJR impact factor of 2,608 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,608.

Alzheimer's Research and Therapy focuses its scope in these topics and keywords: alzheimer’s, disease, patients, impairment, amyloid, memory, endophenotypes, expansionscharacterization, fear, fillings, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cognitive Neuroscience (Q1) Neurology (Q1) Neurology (clinical) (Q1) Neurology (clinical) (Q1)

Price

1529 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

2,608

SJR Impact factor

97

H Index

211

Total Docs (Last Year)

551

Total Docs (3 years)

11291

Total Refs

4384

Total Cites (3 years)

549

Citable Docs (3 years)

7.34

Cites/Doc (2 years)

53.51

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Neurology Q1
Neuro-Oncology Q1
Nature Reviews Neurology Q1
JAMA Neurology Q1
Molecular Neurodegeneration Q1

Compare this journals